In This Article
Press Contact: Andrew Graham
- email: andrew.g@getnugg.com
- text/sms: +1 646 385 0189
Poll Results
 | ||
|---|---|---|
| Q: "The Drug Enforcement Administration has been called out for allegedly working to oppose the cannabis rescheduling proposal. Do you trust the DEA to be an unbiased proponent for cannabis rescheduling?" | ||
| n: | % | |
| Yes | 29 | 4% |
| No | 648 | 96% |
| 677 | ||
Methodology
| NuggMD.com used first-party data to conduct this poll. It was a digital questionnaire sent to a list of people who opted into our polls, all of whom consume cannabis regularly. The poll was conducted from Jan. 16 to Jan. 19. | ||
| n (sample size) | 677 | Respondents: Cannabis consumers |
| z-score | 1.96 | 95% confidence level |
| Margin of error (+/-) | 3.77% | |
NuggMD conducts cannabis consumer polls using first-party data. Roughly half of the sample reports using cannabis mostly or exclusively for medical reasons, while the remainder reports some degree of recreational use. Bear in mind that there is no single source of truth for what constitutes medical versus recreational use beyond the self-selection of the consumer.
Additionally, a majority of the sample reports daily cannabis consumption. It is therefore advisable to assume our polling is over-indexed on medical users and frequent users. The perceptions and behaviors of our sample is likely to be a leading indicator of how the consumer market will trend.
Full data set and demographic break-out available upon request.
